Perrigo (PRGO) EPS (Weighted Average and Diluted) (2012 - 2026)
Perrigo (PRGO) reported EPS (Weighted Average and Diluted) of -$2.87 for Q1 2026, down 5640.0% year-over-year from $0.05 in Q1 2025, and up 71.5% quarter-over-quarter from -$10.07 in Q4 2025.
Perrigo (PRGO) EPS (Weighted Average and Diluted) (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of EPS (Weighted Average and Diluted) data on file, last reported at -$2.87 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$2.87, down 5640.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.95 (down 845.26% YoY), and the FY2025 annual result was -$10.12, down 709.6% from the prior year.
- EPS (Weighted Average and Diluted) grew to -$2.87 in Q1 2026 per PRGO's latest filing, from -$10.07 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.11 in Q3 2023 and troughed at -$10.07 in Q4 2025.
- A 5-year average of -$0.9 and a median of -$0.1 in 2022 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2026: EPS (Weighted Average and Diluted) surged 150.0% in 2024, then plunged 5640.0% in 2026.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.1 in 2022, then tumbled by 100.0% to -$0.2 in 2023, then slumped by 90.0% to -$0.38 in 2024, then tumbled by 2550.0% to -$10.07 in 2025, then jumped by 71.5% to -$2.87 in 2026.
- Business Quant data shows PRGO's EPS (Weighted Average and Diluted) at -$2.87 in Q1 2026, -$10.07 in Q4 2025, and $0.05 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | -2.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -2.87 |
| Dec 31, 2025 | -10.07 |
| Sep 27, 2025 | 0.05 |
| Jun 28, 2025 | -0.06 |
| Mar 29, 2025 | -0.05 |
| Dec 31, 2024 | -0.38 |
| Sep 28, 2024 | -0.15 |
| Jun 29, 2024 | -0.79 |
| Mar 30, 2024 | 0.01 |
| Dec 31, 2023 | -0.20 |
| Sep 30, 2023 | 0.11 |
| Jul 1, 2023 | 0.06 |
| Apr 1, 2023 | -0.02 |
| Dec 31, 2022 | -0.10 |
| Oct 1, 2022 | -0.37 |
| Jul 2, 2022 | -0.48 |
| Apr 2, 2022 | -0.02 |
| Dec 31, 2021 | 0.70 |
| Oct 2, 2021 | -0.40 |
| Jul 3, 2021 | -0.43 |